Gastrointestinal | Lower respiratory tract infection | Acute otitis media | Necrotising enterocolitis (NEC) | Maternal breast cancer (BC) | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
H | p Values | Total | H | p Values | Total | p Values | Total- acute diseases | Treatment costs | Treatment costs | Value health gains* | Total | |
Current treatment costs | 13.42 | 1.33 | 14.75 | 50.25 | 6.65 | 56.90 | 3.85 | 75.5 | 13.54 | 959.50 | NA | 959.50 |
Savings with | ||||||||||||
Policy A1 | 1.20 | 0.14 | 1.34 | 2.16 | 0.30 | 2.46 | 0.28 | 4.08 | ||||
Policy A2 | 3.25 | 0.38 | 3.63 | 5.85 | 0.80 | 6.65 | 0.76 | 11.04 | ||||
Policy A3 | 4.96 | 0.58 | 5.54 | 8.93 | 1.22 | 10.25 | 1.16 | 16.95 | ||||
Policy B1 | 0.56 | 0.07 | 0.63 | 1.00 | 0.14 | 1.14 | 0.13 | 1.9 | ||||
Policy C1 | 1.68 | 0.23 | 1.91 | 4.16 | 0.59 | 4.75 | 0.62 | 7.28 | ||||
Policy D1 | 2.30 | |||||||||||
Policy D2 | 6.12 | |||||||||||
Policy D3 | 9.95 | |||||||||||
Policy E1 | 15.34 | 7.42 | 22.76 | |||||||||
Policy E2 | 21.17 | 10.25 | 31.42 | |||||||||
Policy E3 | 27.80 | 13.46 | 41.26 | |||||||||
Total savings from mid-level policy scenario (Policy A2)—acute diseases | 11.04 | |||||||||||
Total savings from mid-level policy scenario (Policy D2)—NEC | 6.12 | |||||||||||
Total savings from mid-level policy scenario (Policy E2)—BC (without value of health gains) | 21.17 | |||||||||||
Total benefits from mid-level policy scenario (Policy E2)—BC (with value of health gains) | 31.42 |
The italics face is used to differentiate table 3 from table 4. One provides ‘total’, the other provides ‘average’ figures. The bold face highlight policies that are recommended as realistic targets in the discussion section.
*Monetary value of health (QALY) gains @ £20 000/QALY;
NA, Not applicable.
H, hospitalisation costs; P, primary care costs.